Zepp Health (ZEPP) Current Deferred Revenue (2016 - 2025)

Zepp Health's Current Deferred Revenue history runs 10 years deep, the most recent figure standing at $4.7 million for Q4 2025.

• In Q4 2025, Current Deferred Revenue fell 5.7% year-over-year to $4.7 million; the TTM figure through Dec 2025 stood at $4.7 million (down 5.7% YoY), while the FY2025 annual figure was $4.7 million, down 5.7% from the prior year.
• Current Deferred Revenue was $4.7 million for Q4 2025 at Zepp Health, down from $4.9 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $8.6 million in Q4 2022 to a low of $661612.6 in Q4 2021.
• Historically, Current Deferred Revenue has averaged $5.3 million across 5 years, with a median of $4.9 million in 2024.
• The sharpest annual moves came in 2021 and 2022: Current Deferred Revenue slumped 91.53% in 2021, then jumped 1199.84% in 2022.
• A 5-year view of Current Deferred Revenue shows it stood at $661612.6 in 2021, then surged by 1199.84% to $8.6 million in 2022, then declined by 12.82% to $7.5 million in 2023, then tumbled by 34.03% to $4.9 million in 2024, then fell by 5.7% to $4.7 million in 2025.
• The last three Current Deferred Revenue figures came in at $4.7 million (Q4 2025), $4.9 million (Q4 2024), and $7.5 million (Q4 2023), per Business Quant data.